1. Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker
    Elise Semerena et al, 2023, Frontiers in Immunology CrossRef
  2. Visfatin triggers the in vitro migration of osteosarcoma cells via activation of NF-κB/IL-6 signals
    Guang-Ji Wang et al, 2016, European Journal of Pharmacology CrossRef
  3. Visfatin is involved in the cisplatin resistance of osteosarcoma cells via upregulation of Snail and Zeb1
    Dexing Wang et al, 2019, Cancer Biology & Therapy CrossRef
  4. Visfatin Triggers the Cell Motility of Non‐Small Cell Lung Cancer via Up‐Regulation of Matrix Metalloproteinases
    Guanghai Wang et al, 2016, Basic & Clinical Pharmacology & Toxicology CrossRef
  5. Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy
    Christine M. Heske, 2020, Frontiers in Oncology CrossRef
  6. Comprehensive analysis of potential cellular communication networks in advanced osteosarcoma using single-cell RNA sequencing data
    Ning Xu et al, 2022, Frontiers in Genetics CrossRef
  7. Another Weapon against Cancer and Metastasis: Physical-Activity-Dependent Effects on Adiposity and Adipokines
    Silvia Perego et al, 2021, International Journal of Molecular Sciences CrossRef
  8. Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer
    Cristina Travelli et al, 2023, Journal for ImmunoTherapy of Cancer CrossRef
  9. Targeting NAD+ metabolism: dual roles in cancer treatment
    Jiaxin Yong et al, 2023, Frontiers in Immunology CrossRef
  10. SphK1 modulates cell migration and EMT-related marker expression by regulating the expression of p-FAK in colorectal cancer cells
    Chun-Yan Xu et al, 2017, International Journal of Molecular Medicine CrossRef
  11. Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation
    Xiaotong Zhu et al, 2022, Cell Chemical Biology CrossRef
  12. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition
    Zheng Li et al, 2018, Experimental and Molecular Pathology CrossRef
  13. Transforming growth factor-β1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cells
    Yan Qi et al, 2017, PLOS ONE CrossRef
  14. Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism
    Jing Yang et al, 2016, Oncotarget CrossRef
  15. Visfatin facilitates gastric cancer malignancy by targeting snai1 via the NF-κB signaling
    D Cao et al, 2021, Human & Experimental Toxicology CrossRef
  16. Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine
    Ambra A Grolla et al, 2016, British Journal of Pharmacology CrossRef
  17. Mechanism research and treatment progress of NAD pathway related molecules in tumor immune microenvironment
    QinChen Xu et al, 2022, Cancer Cell International CrossRef
  18. Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin
    Federico Carbone et al, 2017, Comprehensive Physiology CrossRef
  19. Adipokines and epithelial-mesenchymal transition (EMT) in cancer
    Ioanna Akrida et al, 2023, Molecular and Cellular Biochemistry CrossRef
  20. Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma
    Kristin Hinton et al, 2023, Biomolecules CrossRef